ROCHE HIVID 0.750 (Hivid 0.75 mg)
Generic Name: zalcitabine
Pill imprint ROCHE HIVID 0.750 has been identified as Hivid 0.75 mg.
Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.75 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for ROCHE HIVID 0.750 (Hivid 0.75 mg)
- Generic Name:
- 0.75 mg
- 11.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
More about Hivid (zalcitabine)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...